Zeina Ahmad Nahleh MD

Oncology•Weston, FL

Chair, Department of Hematology-Oncology Director, Maroon Cancer Center Cleveland Clinic Florida

Join to View Full Profile

2950 Cleveland Clinic BlvdWestonWeston, FL 33331
Phone+1 954-659-5840
Fax+1 954-659-5810

Education & Training

George Washington UniversityFellowship, Hematology and Medical Oncology, 1998 - 2003
American University of Beirut Faculty of MedicineClass of 1995

Certifications & Licensure

FL State Medical License 2017 - 2027
TX State Medical License 2011 - 2017
MI State Medical License 2006 - 2014
OH State Medical License 2003 - 2008
DC State Medical License 2002 - 2004
American Board of Internal Medicine Medical Oncology
Association of Clinical Reserach Professionals (ACRP)Certified Principal Investigator (CPI)

Clinical Trials

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer Start of enrollment: 2005 Sep 01
Withdrawn
Phase 2
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer Start of enrollment: 2010 Apr 01
Completed
Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
ACTIVE_NOT_RECRUITING
PHASE3
AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer Start of enrollment: 2011 Jul 01
Withdrawn
Phase 1, Phase 2
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Start of enrollment: 2012 Oct 03
Terminated
Phase 3
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2014 May 01
Completed
Phase 2
Neoadjuvant Propanolol in Breast Cancer Start of enrollment: 2015 Sep 01
Terminated
Phase 2
Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer Start of enrollment: 2021 Apr 21
COMPLETED
NA
Roles: Principal Investigator, Contact
Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer Start of enrollment: 2021 Aug 12
WITHDRAWN
NA
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

CLO25-082: Predictors of Survival in Breast Cancer With Brain Metastases: A Multi-Center Institutional Experience.
Rami Tfayli, Ali Hijazi, Mohamed Mohanna, Kaylee Sarna, Saad Sabbagh
Journal of the National Comprehensive Cancer Network. 2025-03-28
CLO25-083: Immune-Related Adverse Events in Women With Early and Advanced Triple-Negative Breast Cancer Treated With Pembrolizumab: A Multi-Center Analysis.
Maria Herran, Ahmad Alhalabi, Kaylee Sarna, Theresa Abdo, Rami Tfayli
Journal of the National Comprehensive Cancer Network. 2025-03-28
CLO25-081: The Effect of Delay of Adjuvant Chemotherapy on the Overall Survival in Early-Stage Breast Cancer.
Ahmad Alhalabi, María Herrán, Kaylee Sarna, Theresa Abdo, Rami Tfayli
Journal of the National Comprehensive Cancer Network. 2025-03-28

Lectures

Patterns of systemic treatment utilization in ER+/PgR+/HER2+, early-stage breast cancer (BC): An analysis of the National Cancer Database.
2019 ASCO Annual Meeting - 6/1/2019